
Halper Sadeh LLC is investigating whether certain officers and directors of Sana Biotechnology breached their fiduciary duties to shareholders. Long-term Sana shareholders may seek corporate governance reforms, financial incentives, or other relief. The firm offers free consultations and works on a contingent fee basis, urging shareholders to act quickly due to potential time limits on claims. This investigation could lead to improved company oversight and shareholder value if misconduct is proven.